Chapter/Section Purchase

1 Powerful Analgesics Market Overview
1.1 Product Overview and Scope of Powerful Analgesics
1.2 Powerful Analgesics Segment by Type
1.2.1 Global Powerful Analgesics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Morphine
1.2.3 Hydromorphone
1.2.4 Oxymorphone
1.2.5 Others
1.3 Powerful Analgesics Segment by Application
1.3.1 Global Powerful Analgesics Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Powerful Analgesics Market Size Estimates and Forecasts
1.4.1 Global Powerful Analgesics Revenue 2017-2028
1.4.2 Global Powerful Analgesics Sales 2017-2028
1.4.3 Powerful Analgesics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Powerful Analgesics Market Competition by Manufacturers
2.1 Global Powerful Analgesics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Powerful Analgesics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Powerful Analgesics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Powerful Analgesics Manufacturing Sites, Area Served, Product Type
2.5 Powerful Analgesics Market Competitive Situation and Trends
2.5.1 Powerful Analgesics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Powerful Analgesics Players Market Share by Revenue
2.5.3 Global Powerful Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Powerful Analgesics Retrospective Market Scenario by Region
3.1 Global Powerful Analgesics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Powerful Analgesics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Powerful Analgesics Market Facts & Figures by Country
3.3.1 North America Powerful Analgesics Sales by Country
3.3.2 North America Powerful Analgesics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Powerful Analgesics Market Facts & Figures by Country
3.4.1 Europe Powerful Analgesics Sales by Country
3.4.2 Europe Powerful Analgesics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Powerful Analgesics Market Facts & Figures by Region
3.5.1 Asia Pacific Powerful Analgesics Sales by Region
3.5.2 Asia Pacific Powerful Analgesics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Powerful Analgesics Market Facts & Figures by Country
3.6.1 Latin America Powerful Analgesics Sales by Country
3.6.2 Latin America Powerful Analgesics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Powerful Analgesics Market Facts & Figures by Country
3.7.1 Middle East and Africa Powerful Analgesics Sales by Country
3.7.2 Middle East and Africa Powerful Analgesics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Powerful Analgesics Historic Market Analysis by Type
4.1 Global Powerful Analgesics Sales Market Share by Type (2017-2022)
4.2 Global Powerful Analgesics Revenue Market Share by Type (2017-2022)
4.3 Global Powerful Analgesics Price by Type (2017-2022)
5 Global Powerful Analgesics Historic Market Analysis by Application
5.1 Global Powerful Analgesics Sales Market Share by Application (2017-2022)
5.2 Global Powerful Analgesics Revenue Market Share by Application (2017-2022)
5.3 Global Powerful Analgesics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Mallinckrodt Pharmaceuticals Powerful Analgesics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Alcaliber
6.2.1 Alcaliber Corporation Information
6.2.2 Alcaliber Description and Business Overview
6.2.3 Alcaliber Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Alcaliber Powerful Analgesics Product Portfolio
6.2.5 Alcaliber Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Corporation Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Purdue Pharma Powerful Analgesics Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Sanofi Winthrop Industrie
6.4.1 Sanofi Winthrop Industrie Corporation Information
6.4.2 Sanofi Winthrop Industrie Description and Business Overview
6.4.3 Sanofi Winthrop Industrie Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Winthrop Industrie Powerful Analgesics Product Portfolio
6.4.5 Sanofi Winthrop Industrie Recent Developments/Updates
6.5 Macfarlan Smith
6.5.1 Macfarlan Smith Corporation Information
6.5.2 Macfarlan Smith Description and Business Overview
6.5.3 Macfarlan Smith Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Macfarlan Smith Powerful Analgesics Product Portfolio
6.5.5 Macfarlan Smith Recent Developments/Updates
6.6 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Akorn Powerful Analgesics Product Portfolio
6.6.5 Akorn Recent Developments/Updates
6.7 Barr Pharmaceuticals
6.6.1 Barr Pharmaceuticals Corporation Information
6.6.2 Barr Pharmaceuticals Description and Business Overview
6.6.3 Barr Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Barr Pharmaceuticals Powerful Analgesics Product Portfolio
6.7.5 Barr Pharmaceuticals Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Pfizer Powerful Analgesics Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Watson Laboratories
6.9.1 Watson Laboratories Corporation Information
6.9.2 Watson Laboratories Description and Business Overview
6.9.3 Watson Laboratories Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Watson Laboratories Powerful Analgesics Product Portfolio
6.9.5 Watson Laboratories Recent Developments/Updates
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Teva Powerful Analgesics Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 KV Pharmaceutical
6.11.1 KV Pharmaceutical Corporation Information
6.11.2 KV Pharmaceutical Powerful Analgesics Description and Business Overview
6.11.3 KV Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.11.4 KV Pharmaceutical Powerful Analgesics Product Portfolio
6.11.5 KV Pharmaceutical Recent Developments/Updates
6.12 Lannett
6.12.1 Lannett Corporation Information
6.12.2 Lannett Powerful Analgesics Description and Business Overview
6.12.3 Lannett Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Lannett Powerful Analgesics Product Portfolio
6.12.5 Lannett Recent Developments/Updates
6.13 Apotex
6.13.1 Apotex Corporation Information
6.13.2 Apotex Powerful Analgesics Description and Business Overview
6.13.3 Apotex Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Apotex Powerful Analgesics Product Portfolio
6.13.5 Apotex Recent Developments/Updates
6.14 Fresenius
6.14.1 Fresenius Corporation Information
6.14.2 Fresenius Powerful Analgesics Description and Business Overview
6.14.3 Fresenius Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Fresenius Powerful Analgesics Product Portfolio
6.14.5 Fresenius Recent Developments/Updates
6.15 Johnson and Johnson
6.15.1 Johnson and Johnson Corporation Information
6.15.2 Johnson and Johnson Powerful Analgesics Description and Business Overview
6.15.3 Johnson and Johnson Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Johnson and Johnson Powerful Analgesics Product Portfolio
6.15.5 Johnson and Johnson Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Corporation Information
6.16.2 Mundipharma Powerful Analgesics Description and Business Overview
6.16.3 Mundipharma Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Mundipharma Powerful Analgesics Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Novartis
6.17.1 Novartis Corporation Information
6.17.2 Novartis Powerful Analgesics Description and Business Overview
6.17.3 Novartis Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Novartis Powerful Analgesics Product Portfolio
6.17.5 Novartis Recent Developments/Updates
6.18 Stada Arzneimittel
6.18.1 Stada Arzneimittel Corporation Information
6.18.2 Stada Arzneimittel Powerful Analgesics Description and Business Overview
6.18.3 Stada Arzneimittel Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Stada Arzneimittel Powerful Analgesics Product Portfolio
6.18.5 Stada Arzneimittel Recent Developments/Updates
6.19 Mylan
6.19.1 Mylan Corporation Information
6.19.2 Mylan Powerful Analgesics Description and Business Overview
6.19.3 Mylan Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Mylan Powerful Analgesics Product Portfolio
6.19.5 Mylan Recent Developments/Updates
6.20 Endo Pharmaceuticals
6.20.1 Endo Pharmaceuticals Corporation Information
6.20.2 Endo Pharmaceuticals Powerful Analgesics Description and Business Overview
6.20.3 Endo Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Endo Pharmaceuticals Powerful Analgesics Product Portfolio
6.20.5 Endo Pharmaceuticals Recent Developments/Updates
6.21 Sun Pharmaceutical Industries
6.21.1 Sun Pharmaceutical Industries Corporation Information
6.21.2 Sun Pharmaceutical Industries Powerful Analgesics Description and Business Overview
6.21.3 Sun Pharmaceutical Industries Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Sun Pharmaceutical Industries Powerful Analgesics Product Portfolio
6.21.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.22 Northeast Pharmaceutical Group
6.22.1 Northeast Pharmaceutical Group Corporation Information
6.22.2 Northeast Pharmaceutical Group Powerful Analgesics Description and Business Overview
6.22.3 Northeast Pharmaceutical Group Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Northeast Pharmaceutical Group Powerful Analgesics Product Portfolio
6.22.5 Northeast Pharmaceutical Group Recent Developments/Updates
6.23 Shandong Keyuan Pharmaceutical
6.23.1 Shandong Keyuan Pharmaceutical Corporation Information
6.23.2 Shandong Keyuan Pharmaceutical Powerful Analgesics Description and Business Overview
6.23.3 Shandong Keyuan Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Shandong Keyuan Pharmaceutical Powerful Analgesics Product Portfolio
6.23.5 Shandong Keyuan Pharmaceutical Recent Developments/Updates
7 Powerful Analgesics Manufacturing Cost Analysis
7.1 Powerful Analgesics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Powerful Analgesics
7.4 Powerful Analgesics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Powerful Analgesics Distributors List
8.3 Powerful Analgesics Customers
9 Powerful Analgesics Market Dynamics
9.1 Powerful Analgesics Industry Trends
9.2 Powerful Analgesics Market Drivers
9.3 Powerful Analgesics Market Challenges
9.4 Powerful Analgesics Market Restraints
10 Global Market Forecast
10.1 Powerful Analgesics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Powerful Analgesics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Powerful Analgesics by Type (2023-2028)
10.2 Powerful Analgesics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Powerful Analgesics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Powerful Analgesics by Application (2023-2028)
10.3 Powerful Analgesics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Powerful Analgesics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Powerful Analgesics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer